Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 3.030
+0.105 (3.59%)
Feb 10, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 371.09 million as of February 10, 2026. Its market cap has increased by 25.37% in one year.
Market Cap
371.09M
Enterprise Value
322.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.03
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 371.09M, a decrease of -34.01%. That is a compound annual growth rate of -5.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 371.09M | -9.02% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FluoGuide | 565.69M |
| Corline Biomedical AB | 409.82M |
| Mendus AB | 315.97M |
| Intervacc AB | 313.21M |
| Lipum AB | 288.49M |
| Bio-Works Technologies AB | 272.42M |
| Elicera Therapeutics AB | 255.78M |
| Medivir AB | 251.26M |